Drug interactions involving cimetidine--mechanisms, documentation, implications.
In summary, cimetidine is a potent inhibitor of liver microsomal activity, which may also decrease hepatic blood flow. Other effects of the drug include inhibition of gastric secretion and intrinsic toxic properties. These effects, combined with the common use of cimetidine in clinical practice, make the risk of adverse drug interactions a relatively frequent risk in the clinical setting. Although a multitude of interactions with cimetidine has been evaluated, many of these are incompletely described or understood. At the present time, a potentially significant alteration of absorption appears to exist with only ketoconazole, elemental iron, vitamin B12 (long-term therapy), and pancreatic enzyme supplements (increased activity). Significant metabolic inhibition or decreased excretion appears to exist with warfarin, propranolol, theophylline, phenytoin, quinidine, possibly lidocaine and procainamide, and certain benzodiazepines. Other potential, but less well ascertained interactions may involve the narcotic analgesics, caffeine, ethanol, pentobarbital, imipramine, chlormethiazole, and metronidazole. In these settings, the clinician must be aware of interaction potential, and astutely monitor the patient during combination therapy. Other data indicate that concomitant administration of antacids may reduce the absorption of cimetidine, that the drug may protect against the toxic effects of acetaminophen overdose, and that combination with certain other myelosuppressants may carry a significant risk. Thus, in regard to these reports, cimetidine is a drug with complex effects on the absorption, elimination, and toxicity of other drugs. When used in the setting of multiple drug therapy, the clinician must be alert to potentially increased or decreased effects of the drugs mentioned in this review. In addition, one must be aware that other hepatically metabolised agents not mentioned here may be affected by the addition of cimetidine therapy. Because of the therapeutic successes demonstrated in the treatment of various disorders with cimetidine, one cannot disregard this agent. Thus, the responsibility for understanding and monitoring for the complex effects of this drug falls with the practicing physician.
D000082:Acetaminophen / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000378:metabolism; D000701:Analgesics, Opioid / Q000378:metabolism; D000818:Animals; D000863:Antacids / Q000378:metabolism; D014151:Anti-Anxiety Agents / Q000378:metabolism; D000889:Anti-Arrhythmia Agents / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000378:metabolism; D000925:Anticoagulants / Q000378:metabolism; D000927:Anticonvulsants / Q000378:metabolism; D000935:Antifungal Agents / Q000378:metabolism; D001241:Aspirin / Q000378:metabolism; D001569:Benzodiazepines; D002927:Cimetidine / Q000494:pharmacology*; D004077:Digoxin / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007501:Iron / Q000378:metabolism; D008012:Lidocaine / Q000378:metabolism; D010179:Pancreas / Q000201:enzymology; D010672:Phenytoin / Q000378:metabolism; D011239:Prednisolone / Q000378:metabolism; D013806:Theophylline / Q000378:metabolism; D014805:Vitamin B 12 / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000701:Analgesics, Opioid; D000863:Antacids; D014151:Anti-Anxiety Agents; D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000935:Antifungal Agents; D001569:Benzodiazepines; D000082:Acetaminophen; D010672:Phenytoin; D004077:Digoxin; D002927:Cimetidine; D008012:Lidocaine; D011239:Prednisolone; D013806:Theophylline; D007501:Iron; D014805:Vitamin B 12; D001241:Aspirin